Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age - Concepedia

Concepedia

Publication | Open Access

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

DOI Full Paper Access

156

Citations

28

References

2020

Year

Donald Hurley, Carl Griffin, Mariano Young, Daniel A. Scott, Michael W. Pride, Ingrid L. Scully, John Ginis, Joseph M. Severs, Kathrin U. Jansen, William C. Gruber,

Clinical Infectious Diseases

Abstract

NCT03313037.

References

	Year	Citations

Page 1